Workflow
LHV Group Financial Calendar for 2026
Globenewswire· 2025-09-18 13:00
AS LHV Group has decided the company’s Financial Calendar for the 2026 financial year. In 2026 LHV Group plans to disclose information and organise the Annual General Meeting of shareholders according to the following schedule: 10.02.2026Q4 2025 and unaudited full year results12.02.2026Disclosure of Financial Plan17.02.2026January results03.03.2026Audited results for 202517.03.2026February results25.03.2026Annual General Meeting09.04.2026Ex-dividend date (ex-date)<td style="width:160.34px;;text-align: cente ...
Biotalys Reports Half-Year 2025 Financial Results and Business Highlights
Globenewswire· 2025-09-18 13:00
Press release - regulated informationGhent, Belgium, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Substantial progress in both the U.S. and Europe in the regulatory review of Biotalys’ first candidate biofungicide EVOCA™*Patent protection for EVOCA in Brazil and China, and for a BioFun-6 lead candidate in the U.S.Strategic partnership with AgroFresh to expand into post-harvest segmentLeadership team expanded with proven industry executives Cash and cash equivalents amounted to €15.7 million as of the end of June 202 ...
BUZZ HPC Closes Acquisition of 7.2 MW Toronto Site to Build Data Centre for Sovereign AI Infrastructure
Newsfile· 2025-09-18 13:00
BUZZ HPC Closes Acquisition of 7.2 MW Toronto Site to Build Data Centre for Sovereign AI InfrastructureSeptember 18, 2025 1:00 AM EDT | Source: HIVE Digital Technologies Ltd.This news release constitutes a "designated news release" for the purposes of the Company's amended and restated prospectus supplement dated May 14, 2025, to its short form base shelf prospectus dated September 11, 2024.Vancouver, British Columbia--(Newsfile Corp. - September 18, 2025) - BUZZ High Performance Computing ("B ...
Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH
Globenewswire· 2025-09-18 13:00
89bio’s pegozafermin allows for a potentially best-in-disease treatment for moderate to severe Metabolic Dysfunction-Associated Steatohepatitis (MASH), one of the most prevalent comorbidities of obesityAcquisition supports Roche’s strategy as it enhances the company’s portfolio in cardiovascular, renal, and metabolic diseases (CVRM) and offers optionality for future combination developmentRoche to acquire 89bio for US$14.50 per share in cash at closing, representing a total equity value of approximately US$ ...
China drops Google antitrust probe during US trade talks, FT reports
Reuters· 2025-09-18 12:37
China is dropping an antitrust probe into Google, as Beijing and Washington step up trade negotiations over TikTok and Nvidia at a time of heightened tensions between the two countries, the Financial ... ...
Michael Reitermann takes over the operational leadership of the Ascom Group as Delegate of the Board of Directors and interim CEO
Globenewswire· 2025-09-18 12:30
Ad hoc announcement pursuant to Art. 53 LR Baar, Switzerland, 18 September 2025Michael Reitermann, Member of the Board of Directors since 2020, and an executive leader with broad experience both in the USA and Europe, has been appointed by the Board of Directors of Ascom Holding AG as Delegate of the Board of Directors and interim CEO. He takes over the operational leadership from Nicolas Vanden Abeele, who decided to leave Ascom after nearly four years as CEO to pursue new professional challenges.The Board ...
CGTX, RVPH, SHOT, SONN, AKTX Rally After-Hours On Clinical Updates And Fed Rate Cut Momentum
RTTNews· 2025-09-18 12:25
Biotech and healthcare stocks continue to respond sharply to progress in clinical trials, regulatory developments, and broader economic indicators. With the Federal Reserve initiating its first rate cut of 2025 and signaling a more accommodative stance, capital-intensive sectors such as biotechnology are likely to benefit from improved funding conditions and renewed market interest. Against this backdrop, several companies have seen notable price movement after hours, driven by pipeline progress, financing ...
Flux Power: Sell On Poor Outlook And Elevated Dilution Risk
Seeking Alpha· 2025-09-18 12:24
I am mostly a trader engaging in both long and short bets intraday and occasionally over the short- to medium term. My historical focus has been mostly on tech stocks but over the past couple of years I have also started broad coverage of the offshore drilling and supply industry as well as the shipping industry in general (tankers, containers, drybulk). In addition, I am having a close eye on the still nascent fuel cell industry.I am located in Germany and have worked quite some time as an auditor for Pric ...
Panasonic aims to develop groundbreaking EV battery in about two years
Reuters· 2025-09-18 12:23
Panasonic aims to develop a new type of higher-capacity battery in about two years, potentially extending the driving range of electric vehicles in a groundbreaking advance for the Tesla supplier. ...
Spirit Airlines is cutting flights by 25% as it restructures again
Business Insider· 2025-09-18 12:17
Spirit Airlines is set to reduce its flights by 25% as it struggles with a second bankruptcy filing. In a memo to staff on Wednesday, CEO Dave Davis said the airline would be "redesigning and strengthening" its flight network starting in November."As planning begins, you will see a reduction of about 25% in capacity, year over year, as we optimize our network to focus on our strongest markets," David said in the memo, seen by Business Insider. A representative of Spirit did not respond to a follow-up quer ...